Literature DB >> 974969

Mebendazole in the treatment of helminthiasis.

S K Seah.   

Abstract

Mebendazole, a new broad-spectrum anthelmintic, was used to treat patients with nematode infections--ascariasis, trichuriasis and hookworm. The dosage for adults was 100 mg twice daily for 3 days and for children, 50 mg twice daily for 3 days. Pretreatment and post-treatment egg counts on stool specimens showed that after mebendazole there was a reduction of over 99% in egg count per gram of stool in all three types of infection. The overall cure rates for the infections were as follows: Ascaris lumbricoides, 86.8% (59/68); Trichuris trichiura, 86.0% (37/43); and hookworm, 85.7% (24/28). The drug was equally effective in light and heavy infections. No important side effect was noted with this drug. It is suggested that mebendazole is the drug of choice for trichuriasis and mixed nematode infection.

Entities:  

Keywords:  Diseases; Evaluation; Men; Parasitic Diseases; Treatment; Women

Mesh:

Substances:

Year:  1976        PMID: 974969      PMCID: PMC1878825     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  13 in total

1.  The value of formol-ether concentration of faecal cysts and ova.

Authors:  D S RIDLEY; B C HAWGOOD
Journal:  J Clin Pathol       Date:  1956-02       Impact factor: 3.411

2.  A clinical evaluation of mebendazole in the treatment of trichuriasis.

Authors:  R G Sargent; A M Savory; A Mina; P R Lee
Journal:  Am J Trop Med Hyg       Date:  1974-05       Impact factor: 2.345

3.  The use of mebendazole in the treatment of polyparasitism.

Authors:  F Partono; A Tangkilisan
Journal:  Southeast Asian J Trop Med Public Health       Date:  1974-06       Impact factor: 0.267

4.  Intestinal capillariasis. A new disease in man.

Authors:  G E Whalen; E B Rosenberg; G T Strickland; R A Gutman; J H Cross; R H Watten
Journal:  Lancet       Date:  1969-01-04       Impact factor: 79.321

5.  Editorial: A new anthelmintic.

Authors:  J D Archer
Journal:  JAMA       Date:  1974-12-04       Impact factor: 56.272

6.  Mebendazole, an effective broad-spectrum anthelmintic.

Authors:  A P Chavarría; J C Swartzwelder; V M Villarejos; R Zeledón
Journal:  Am J Trop Med Hyg       Date:  1973-09       Impact factor: 2.345

7.  Toxicologic studies on mebendazole.

Authors:  R Marsboom
Journal:  Toxicol Appl Pharmacol       Date:  1973-03       Impact factor: 4.219

8.  Treatment of trichuriasis.

Authors:  M M Lenczner
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

9.  Mebendazole in enterobiasis. Radiochemical and pilot clinical study in 1,278 subjects.

Authors:  J P Brugmans; D C Thienpont; I van Wijngaarden; O F Vanparijs; V L Schuermans; H L Lauwers
Journal:  JAMA       Date:  1971-07-19       Impact factor: 56.272

10.  Clinical trials with mebendazole a new broad spectrum anthelmintic.

Authors:  B J Vakil; N J Dalal; E Enjetti
Journal:  J Trop Med Hyg       Date:  1975-07
View more
  2 in total

1.  Transcriptome sequencing and analysis of the zoonotic parasite Spirometra erinacei spargana (plerocercoids).

Authors:  Dae-Won Kim; Won Gi Yoo; Myoung-Ro Lee; Hye-Won Yang; Yu-Jung Kim; Shin-Hyeong Cho; Won-Ja Lee; Jung-Won Ju
Journal:  Parasit Vectors       Date:  2014-08-15       Impact factor: 3.876

2.  Synthesis, characterization and in vitro, in vivo, in silico biological evaluations of substituted benzimidazole derivatives.

Authors:  Sabreena Chowdhury Raka; Arifur Rahman; Fahad Hussain; S M Abdur Rahman
Journal:  Saudi J Biol Sci       Date:  2021-08-28       Impact factor: 4.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.